Corpus Intelligence IC Memo — ASCENSION PROVIDENCE HOSPITAL 2026-04-26 04:03 UTC
IC Memo — ASCENSION PROVIDENCE HOSPITAL
Investment Committee Memorandum | MI | 527 beds | Grade C | EBITDA uplift $62.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ASCENSION PROVIDENCE HOSPITAL

CCN 230019 | OAKLAND, MI | 527 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ASCENSION PROVIDENCE HOSPITAL is a 527-bed suburban community hospital in OAKLAND, MI with $849.3M in net patient revenue and a -6.5% operating margin. The hospital serves a payer mix of 24.5% Medicare, 3.1% Medicaid, and 72.3% commercial.

Thesis: Undervalued. Our ML models identify $62.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -6.5% to 0.8% (+736bps).

Net Revenue HCRIS$849.3M
Current EBITDA COMPUTED$-55.6M
Operating Margin COMPUTED-6.5%
Occupancy HCRIS78.4%
Revenue / Bed COMPUTED$1.6M
Net-to-Gross HCRIS30.3%
Distress Probability ML42.1%

2. Market Context & Competitive Position

163
MI Hospitals
-5.2%
State Median Margin
24
Comparable Hospitals

MI has 163 Medicare-certified hospitals with a median operating margin of -5.2%. The target's margin of -6.5% places it below the state median. Among 24 size-comparable peers (264-1054 beds), the median margin is -7.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (264-1054), prioritizing same-state peers. 24 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ASCENSION PROVIDENCE HOSPITAL (Target)MI527$849.3M-6.5%
UNIV OF MI HOSPITALS & HLTH CTMI951$4.62B-1.4%
HENRY FORD HOSPITALMI670$2.32B-14.8%
WILLIAM BEAUMONT HOSPITAL- ROYMI1026$1.56B-0.8%
BRONSON METHODIST HOSPITALMI439$1.06B-1.4%
TRINITY HEALTH ANN ARBORMI475$1.00B-1.0%
EDWARD W. SPARROW HOSPITALMI425$936.1M-24.5%
ASCENSION ST JOHN HOSPITALMI556$929.1M-9.6%
WILLIAM BEAUMONT HOSPITAL - TRMI484$747.4M2.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $62.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$17.8M+210bp18mo
Cost to Collect4.5%2.5%$17.0M+200bp12mo
Denial Rate Reduction12.0%6.5%$16.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$10.3M+122bp9mo
Clean Claim Rate88.0%96.0%$544K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$17.8M
Cost to Collect
$17.0M
Denial Rate Reduction
$16.8M
A/R Days Reduction
$10.3M
Clean Claim Rate
$544K
Total EBITDA Uplift$62.5M
Current EBITDA$-55.6M
+ RCM Uplift+$62.5M
Pro Forma EBITDA$7.0M
Current Margin-6.5%
Pro Forma Margin0.8%
WC Released (1x)$32.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-85.5M$258.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-85.5M$256.7M0.00x-100.0%
Bull Case9.0x11.0x$-76.9M$435.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-76.9M$452.1M0.00x-100.0%
Bear Case11.0x10.0x$-94.0M$-26.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-94.0M$-59.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 24 hospitals with 264-1054 beds
  • Same-state prioritization (n=25)
  • Comp margins: P25=-10.3% / P50=-7.1% / P75=-1.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.